Logo

American Heart Association

  26
  0


Final ID:

Biomarkers for Cardiotoxicity Monitoring: Do We Really Need Them, Or Are They Just Extra Baggage? (Con)

  • Nohria, Anju  ( Brigham and Womens Hospital , Boston , Massachusetts , United States )
  • Asnani, Aarti  ( Beth Israel Deaconess , Arliton , Massachusetts , United States )
  • Author Disclosures:
    Anju Nohria: DO have relevant financial relationships ; Research Funding (PI or named investigator):Bristol Myers Squibb:Active (exists now) ; Other (please indicate in the box next to the company name):Teledoc:Active (exists now) ; Other (please indicate in the box next to the company name):American College of Cardiology:Active (exists now) ; Consultant:Takeda Oncology:Active (exists now) ; Consultant:Regeneron:Past (completed) ; Consultant:Altathera:Past (completed) ; Consultant:AstraZeneca:Active (exists now) | Aarti Asnani: DO have relevant financial relationships ; Research Funding (PI or named investigator):Genentech:Active (exists now) ; Royalties/Patent Beneficiary:UpToDate:Active (exists now) ; Speaker:OncLive:Past (completed) ; Ownership Interest:Corventum:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Great Debates in Cardio-Oncology: Let's Agree to Disagree

Saturday, 11/16/2024 , 03:15PM - 04:30PM

Cardiovascular Seminar

More abstracts on this topic:
Biomarkers for Cardiotoxicity Monitoring: Do We Really Need Them, Or Are They Just Extra Baggage? (Pro)

Cardinale Daniela, Lopez-fernandez Teresa, Scherrer-crosbie Marielle

Guidelines in Cardio-Oncology: Ready for Prime Time? (Pro)

Plana Juan, Lyon Alexander, Van Der Meer Peter, Yang Eric

More abstracts from these authors:
Optimizing Mouse Models of Doxorubicin Cardiomyopathy

Curtin Casie, Liu Jing, Basu Sandeep, Weitzman Benjamin, Wieke Jakob, Asnani Aarti

Building a Cardio-oncology Program

Asnani Aarti, Barac Ana, Clasen Suparna

You have to be authorized to contact abstract author. Please, Login
Not Available